Cargando…
Genetic polymorphisms and non-small-cell lung cancer: future paradigms
This article addresses some current issues about genetic polymorphisms studied in the non-small-cell lung cancer translational field. Furthermore, it discusses about new potential biomarkers regarding lung cancer risk and prognosis.
Autor principal: | de Mello, Ramon Andrade Bezerra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879925/ https://www.ncbi.nlm.nih.gov/pubmed/25628210 http://dx.doi.org/10.1590/S1679-45082014RB2906 |
Ejemplares similares
-
Back to EGF+61 genetic polymorphisms and lung cancer risk: looking to the future!
por: Mello, Ramon Andrade De
Publicado: (2013) -
Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives
por: De Mello, Ramon Andrade Bezerra, et al.
Publicado: (2021) -
Genetic Polymorphism of CYP2A6 and Its Relationship with Nicotine Metabolism in Male Bataknese Smokers Suffered from Lung Cancer in Indonesia
por: Soeroso, Noni Novisari, et al.
Publicado: (2018) -
Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside
por: de Mello, Ramon Andrade, et al.
Publicado: (2020) -
Genetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies
por: Qu, Hui‐Qi, et al.
Publicado: (2022)